Ziegler Capital Management’s AbbVie ABBV Stock Holding History

Ziegler Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$9.55M	Buy	52,715 +24,174	+85%	+$4.17M	0.36%	89
2023 Q4	$4.44M	Sell	28,541 -1,654	-5%	-$241K	0.2%	116
2023 Q3	$4.5M	Sell	30,195 -5,885	-16%	-$864K	0.18%	172
2023 Q2	$4.86M	Sell	36,080 -41,043	-53%	-$6.02M	0.19%	170
2023 Q1	$12.3M	Sell	77,123 -1,888	-2%	-$289K	0.49%	56
2022 Q4	$12.7M	Sell	79,011 -5,424	-6%	-$832K	0.53%	46
2022 Q3	$11.4M	Sell	84,435 -3,111	-4%	-$446K	0.5%	54
2022 Q2	$13.4M	Buy	87,546 +9,751	+13%	+$1.49M	0.55%	37
2022 Q1	$12.6M	Sell	77,795 -9,146	-11%	-$1.33M	0.53%	65
2021 Q4	$11.8M	Sell	86,941 -4,375	-5%	-$517K	0.42%	95
2021 Q3	$9.85M	Sell	91,316 -13,613	-13%	-$1.56M	0.36%	108
2021 Q2	$11.8M	Buy	104,929 +3,971	+4%	+$447K	0.4%	93
2021 Q1	$10.9M	Buy	100,958 +13,200	+15%	+$1.41M	0.34%	107
2020 Q4	$9.4M	Sell	87,758 -2,445	-3%	-$235K	0.31%	119
2020 Q3	$7.9M	Buy	90,203 +36,620	+68%	+$3.45M	0.3%	107
2020 Q2	$5.26M	Sell	53,583 -44,978	-46%	-$3.96M	0.17%	184
2020 Q1	$7.51M	Buy	+98,561	New	+$8.4M	0.2%	145
2013 Q3	$3.14M	Buy	70,160 +22,302	+47%	+$989K	0.27%	103
2013 Q2	$1.98M	Buy	+47,858	New	+$2.09M	0.21%	146

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ziegler Capital Management's ABBV Position: Q1 2024 in Review

Ziegler Capital Management increased its AbbVie (ABBV) stake by 85% in Q1 2024, buying an estimated $4.17M and bringing the position to 52,715 shares worth $9.55M. The position accounts for 0.36% of the portfolio, ranked #89.

Ziegler Capital Management first reported a position in ABBV in Q2 2013 and has held it in 19 quarters since. The position peaked at $13.4M in Q2 2022. 3,380 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

Ziegler Capital Management held 52,715 shares of AbbVie worth $9.55M as of Q1 2024.
Ziegler Capital Management bought 24,174 AbbVie shares in Q1 2024, an estimated $4.17M.
AbbVie made up 0.36% of Ziegler Capital Management's portfolio in Q1 2024, its #89 holding.
Ziegler Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 19 quarters since.
Ziegler Capital Management's AbbVie position peaked at $13.4M in Q2 2022.
3,380 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Ziegler Capital Management's 13F filing for Q1 2024, filed 15 May 2024.